Tapentadol is a centrally acting opioid analgesic of the benzenoid class, indicated for the management of moderate to severe acute or chronic pain, including musculoskeletal pain and diabetic neuropathy.… Read more

































Tapentadol is a centrally acting opioid analgesic of the benzenoid class, indicated for the management of moderate to severe acute or chronic pain, including musculoskeletal pain and diabetic neuropathy. The drug functions through a dual mechanism of action, acting as both a μ-opioid receptor agonist and a norepinephrine reuptake inhibitor. This category contains a comprehensive collection of reference standards necessary for stringent quality control and regulatory compliance, including the active pharmaceutical ingredient (API), pharmacopeial and non-pharmacopeial impurities, and relevant metabolites such as N-desmethyl tapentadol and various glucuronides. Laboratories utilize these high-quality materials for impurity profiling, analytical method development, and validation studies. Additionally, the availability of stable isotope labelled compounds provides essential internal standards for precise quantification during complex bioanalytical procedures and pharmacokinetic assessments, ensuring accurate monitoring of drug stability and degradation pathways.